David Bouchey
Stock Analyst at Aegis Capital
(0)
# 5229
Out of 5,279 analysts
7
Total ratings
0.00%
Success rate
-72.43%
Average return
Main Sectors:
| Name | Action | Price Target | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
Sunshine Biopharma | Reiterates: Buy | 15 15 | 2.12 | 607.55% | 2 | Dec 5, 2024 | |
Sharps Technology | Initiates Coverage On: Buy | 352 | 0.3 | 117233.33% | 1 | May 9, 2023 | |
Avenue Therapeutics | Initiates Coverage On: Buy | 2400 | 0.99 | 242324.24% | 1 | Apr 3, 2023 | |
Inspira Technologies... | Maintains: Buy | 10 13 | 0.76 | 1610.53% | 1 | Jan 25, 2023 | |
Rockwell Medical | Downgrades: Outperform | 121 | 1.63 | 7323.31% | 2 | Oct 19, 2018 |